Proposed Framework for Leveraging a Distributed Pan-cancer Profiling IVD as a Companion Diagnostic for Oncology Targeted Molecular Therapies
Published online. September 9, 2024. Boudicca DX, LLC All rights reserved.
Disclaimer: The opinions expressed in this white paper are solely those of Boudicca DX, LLC and do not reflect those of any entity mentioned.
PRAGMATIC NAVIGATION OF EU IVDR TO ACCELERATE CLINICAL TRIALS FOR TARGETED PRECISION THERAPIES IN EUROPE
If you are working in Biopharma and struggling to navigate EU IVDR, e-mail courtney@boudiccadx.com (include your Biopharma company name in the subject line) for a copy of this 35 page white paper that offers solutions informed by Boudicca DX™ regulatory intelligence and decades of clinical biomarker and drug development experience both in the EU and US.
Disclaimer: The opinions expressed in this white paper are solely those of Boudicca DX, LLC and do not reflect those of any entity mentioned.
Published August 18, 2025. Boudicca DX, LLC All rights reserved.
